Carmen Chang is > 10% Shareholder of Mirum Pharmaceuticals, Inc.. Currently has a direct ownership of 135 shares of MIRM, which is worth approximately $5,603. The most recent transaction as insider was on Jun 13, 2023, when has been sold 135 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 135
0% 3M change
0% 12M change
Total Value Held $5,603

Carmen Chang Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 13 2023
BUY
Other acquisition or disposition
-
135 Added 50.0%
135 Common Stock

Also insider at

RGLS
Regulus Therapeutics Inc. Healthcare
MRKR
Marker Therapeutics, Inc. Healthcare
BHG
Bright Health Group Inc. Healthcare
GLUE
Monte Rosa Therapeutics, Inc. Healthcare
TRVI
Trevi Therapeutics, Inc. Healthcare
COUR
Coursera, Inc. Consumer Defensive
MTCR
Metacrine, Inc. Healthcare
GNCA
GENOCEA BIOSCIENCES, INC. Healthcare
AKUS
Akouos, Inc. Healthcare
SVRA
Savara Inc Healthcare
FREQ
Frequency Therapeutics, Inc. Healthcare
MBX
MBX Biosciences, Inc.
CC

Carmen Chang

> 10% Shareholder
Menlo Park, CA

Track Institutional and Insider Activities on MIRM

Follow Mirum Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MIRM shares.

Notify only if

Insider Trading

Get notified when an Mirum Pharmaceuticals, Inc. insider buys or sells MIRM shares.

Notify only if

News

Receive news related to Mirum Pharmaceuticals, Inc.

Track Activities on MIRM